GW Henssler & Associates’s Nuveen Short-Term REIT ETF NURE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-416,860
Closed -$12.4M 216
2022
Q3
$12.4M Buy
416,860
+30,897
+8% +$1.04M 0.93% 48
2022
Q2
$12.4M Sell
385,963
-13,834
-3% -$495K 0.92% 47
2022
Q1
$15.6M Buy
399,797
+14,591
+4% +$557K 0.95% 44
2021
Q4
$15.7M Buy
385,206
+7,313
+2% +$279K 1% 41
2021
Q3
$13.3M Buy
+377,893
New +$13.6M 0.93% 50

Other funds holding NURE

GW Henssler & Associates's NURE Position: Q4 2022 in Review

GW Henssler & Associates sold out of Nuveen Short-Term REIT ETF (NURE) in Q4 2022, closing a stake of 416,860 shares — an estimated $12.4M sold.

GW Henssler & Associates first reported a position in NURE in Q3 2021 and held it in 5 quarters. The position peaked at $15.7M in Q4 2021. 38 funds tracked by Wall St. Rank hold NURE as of Q4 2022.

  • GW Henssler & Associates reported no remaining Nuveen Short-Term REIT ETF position as of Q4 2022 after selling out during the quarter.
  • GW Henssler & Associates sold 416,860 Nuveen Short-Term REIT ETF shares in Q4 2022, an estimated $12.4M.
  • GW Henssler & Associates first reported a position in Nuveen Short-Term REIT ETF in Q3 2021 and held it in 5 quarters.
  • GW Henssler & Associates's Nuveen Short-Term REIT ETF position peaked at $15.7M in Q4 2021.
  • 38 funds tracked by Wall St. Rank held Nuveen Short-Term REIT ETF as of Q4 2022.

Based on GW Henssler & Associates's 13F filing for Q4 2022, filed 3 Feb 2023.